Precision genomics is revolutionizing our understanding of disease. By analyzing an individual's unique genetic makeup, we can pinpoint potential risks and develop customized treatment plans. This strategy holds immense potential for augmenting patient outcomes and progressing healthcare into a n

during the validation phase, we compared the above-outlined seven genes by MethLight qPCR system in Chinese Han males (N = 109 SCZ sufferers, N = 99 methamphetamine use ailment with MIP people, N = 150 methamphetamine use problem without MIP people, N = 282 regular controls, age variety: eighteen